Biotechnology
Medical
Biopharmaceutical

Puma Biotechnology

$10.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.31 (-2.87%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell PBYI and other stocks, options, ETFs, and crypto commission-free!

About PBYI

Puma Biotechnology Inc Common Stock, also called Puma Biotechnology, is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. Read More The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Employees
272
Headquarters
Los Angeles, California
Founded
2010
Market Cap
416.20M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.13M
High Today
$11.11
Low Today
$10.41
Open Price
$10.92
Volume
1.21M
52 Week High
$54.20
52 Week Low
$10.41

Collections

Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
Cancer Prevention
Technology

PBYI Earnings

-$1.98
-$1.41
-$0.83
-$0.26
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.